[1]
E. Kerboua1, Z.Benlahrech2, R.Benyahia3, “Sorafenib in iodo-refractory thyroid cancer : Experience of medical oncology department of Pierre and Marie Curie Center Algiers Algeria ”, ijmscrr, vol. 7, no. 03, pp. Page: 494–496, May 2024.